EUVIMEDEUVIMED entdecken
Crossref

Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion

Athinoula Meli iD, David Healy, Gina Howarth, Shane Grimsley, Helen V New, Suzy Morton iD, Ulrike Paulus

Vox Sanguinis · 2026-06 · 121 (6) · 809-813

DOI: 10.1111/vox.70244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 12.03.2026. Verfasst von Athinoula Meli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK. Hauptthemen laut MEDLINE: Blood Transfusion, Intrauterine, Erythrocytes, Cryopreservation, Blood Preservation. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Provision of red cells for intrauterine transfusion (IUT) can be challenging when the mother has an antibody to a high frequency antigen, as compatible allogeneic red cells may be scarce. The aim was to validate a novel component: split, frozen, thawed, washed and irradiated red cells for IUT, which could be used if foetal transfusion with maternal blood is necessary. Materials and Methods Six standard red cell concentrates were glycerolized on Day 5 and split into three smaller packs before freezing. A split from each donation was thawed and deglycerolized using the ACP215 and resuspended in saline‐adenine‐glucose‐mannitol. The haematocrit was adjusted to IUT (70%–85%). The components, each approximately 80 mL, were immediately irradiated and tested for full blood count, haemolysis and supernatant potassium 8 and 24 h later.

Results

At 8 and 24 h post manufacture, haemolysis was 0.20% (0.16%–0.25%) and 0.24% (0.18%–0.29%), respectively, and supernatant potassium was 20.3 mmol/L (15.1–27.1 mmol/L) and 43.1 mmol/L (33.5–58.4 mmol/L), respectively (mean [range]). Both haemolysis and potassium were within levels for standard irradiated IUT units.

Conclusion

Red cells split, frozen, thawed, washed and manufactured into IUT units and immediately irradiated are expected to be a beneficial component for very rare clinical cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Transfusion, IntrauterineErythrocytesCryopreservationBlood PreservationErythrocyte TransfusionHumansFemalePregnancyHemolysis

Stichwörter der Autor:innen

alloimmunizationintrauterine transfusionsplit red cellsthawed and washed red cells

Autor:innen und Institutionen

  • Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK.
  • National Frozen Blood Bank, NHS Blood and Transplant, Liverpool, UK.
  • International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK.
  • Clinical Directorate, NHS Blood and Transplant, London, UK.
  • Clinical Directorate, NHS Blood and Transplant, Birmingham, UK.
  • Clinical Directorate, NHS Blood and Transplant, Filton, UK.

ORCID-Profile: Athinoula Meli, Suzy Morton

Zitieren

APA

Meli, A., Healy, D., Howarth, G., Grimsley, S., New, H. V., Morton, S., & Paulus, U. (2026). Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion. Vox Sanguinis, 121(6), 809-813. https://doi.org/10.1111/vox.70244

Vancouver

Meli A, Healy D, Howarth G, Grimsley S, New HV, Morton S, et al. Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion. Vox Sanguinis. 2026;121(6):809-813. doi:10.1111/vox.70244

BibTeX
@article{Meli2026,
  author = {Meli, Athinoula and Healy, David and Howarth, Gina and Grimsley, Shane and New, Helen V and Morton, Suzy and Paulus, Ulrike},
  title = {Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion},
  journal = {Vox Sanguinis},
  year = {2026},
  volume = {121},
  number = {6},
  pages = {809--813},
  doi = {10.1111/vox.70244}
}
Kostenlos starten →